Design Therapeutics

DSGNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$785.400 M

$12.55 +2.53%

Close of 21 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$69.8M

Loss-making

Shares outstanding

62,581,651

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#176BlossomHill TherapeuticsBLSM$810.8M
#177AnnexonANNX$800.0M
#178Design TherapeuticsDSGN$785.4M
#179Climb BioCLYM$783.4M
#180Pharming GroupPHAR$763.5M

What if Design Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$483,752.88

Per share 38,546× higher

Bitcoin $1.72T

$27,480.96

Per share 2,190× higher

Nvidia $5.48T

$87,563.33

Per share 6,977× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Design Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.